Site Search

Share

X

Search Results

State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments

Video with cancer survivor’s story here . Sacramento, Calif. –  The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help ... California Legislative Director for ACS CAN. “Improving coverage for and access to biomarker testing across insurance types is key to reducing health inequities and improving cancer outcomes.” For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...

2022 ACS CAN North Dakota Policy Power Hours

... to be a lively and insightful event. Our policy presentation will spotlight the impact of the Cancer Moonshot and cancer research on patient care in North Dakota. This event is open to all survivors, caregivers, advocates, researchers, medical staff, lawmakers, and whomever is moved by ... the 2022 ACS CAN North Dakota Policy Power Hour might look different this year but our passion and commitment to fight cancer is unchanged. The health and safety of all our guests and participants is our number one goal. Please see below for important details which will continue to be ... sick or have been recently exposed to someone who recently tested positive for COVID-19, you should stay home. People who have underlying health conditions or taking medications that weaken the immune system, should talk to their healthcare provider before attending large gatherings. ...

New Survey Shows Clear Need for Paid Leave Among Cancer Patients and Survivors

... said Lisa Lacasse, president of ACS CAN. “Yet bills and expenses continue to mount. We need to do everything we can to ensure people can care for themselves and their loved ones without facing financial devastation.” Forty-three percent of those surveyed said the financial effect ... very difficult. Just 3% of higher income earners (earning over $125,000 annually) report losing their job due to the time they missed for cancer care, compared to 31% of those earning under $70,000 per year.   According to the U.S. Census, more than 54 percent of the U.S. population ... access to short-term disability insurance through their jobs that allows them to receive partial pay while they recover from their own serious health issue. Fewer than 60 percent of workers qualify for job-protected, unpaid leave under the Family and Medical Leave Act (FMLA), and workers ...

Expand Access to Biomarker Testing in Vermont

... are working together to make sure more Vermont residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Expand Access to Biomarker Testing in New Hampshire

... are working together to make sure more New Hampshire residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Expand Access to Biomarker Testing in Maine

... are working together to make sure more Maine residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

American Cancer Society and American Cancer Society Cancer Action Network Name Dr. Karen Knudsen as Next CEO

... serves as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health, one of only 71 National Cancer Institute-Designated Cancer Centers recognized for its research and impact on cancer outcomes. She ... with volunteers and staff to shape the vision and deliver tangible results.   “As director of the Sidney Kimmel Cancer Center at Jefferson Health, I've experienced firsthand how the American Cancer Society improves the lives of cancer patients and their families through ... Knudsen currently serves as president, is also an important voice in advocating for funding for cancer research and access to care, including patient access to research innovations. AACI is a member of the One Voice Against Cancer Coalition, which was founded by ACS ...

ACS CAN Applauds NYS Senate for Passing Legislation to Improve Vaccine Access in Pharmacies

... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to ...

"If it is good enough for a Member of Congress..."

It has long been suggested that the American public should have access to the same health coverage as Members of Congress. So, ACS CAN decided to look at what Members get and see just how good it would be for someone who gets ... out-of-pocket limit in this plan is Š—“hardŠ— meaning patient costs above the limit are fully covered for in-network and out-of-network care. For example, a woman with stage II breast cancer would have out-of-pocket costs of between $10,000-$13,000 (depending on how many services ...

White House Shines National Spotlight on Cancer to Reignite Moonshot

... it,’ building on the initial and robust cancer moonshot investment in discovery, prioritizing increased uptake of prevention and addressing health disparities. The American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), ... detection tests for cancers for which we don’t currently have answers. We must also ensure everyone has access to affordable, comprehensive health care coverage and can take a significant step toward that goal by closing the Medicaid coverage gap. Finally, we must work to ensure no matter how ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy